1q21-25 is one of the 'hotspots' of chromosomal alteration, including duplications and translocations, frequently detected in hematological malignancies. As a consequence of these aberrations, genes may become deregulated or fusion genes may be formed and interfere with the normal programs of cell growth and differentiation. We report here on a patient with t (1;2)(q21;q37) occurring in acute myeloid leukemia (AML) with antecedent myelodysplastic syndrome (MDS).
The patient was a 71-year-old male (case #30 in SIH-MDS series) who was diagnosed as having progressive MDS.
Hematologic data were as follows: red blood cells 2.87 Â 10 12 /l, hemoglobin 83 g/l, white blood cells 14.9 Â 10 9 / l and a platelet count of 34 Â 10 9 /l. Bone marrow (BM) biopsy: the marrow was hypercellular. The M/E ratio was normal. Myeloblasts and promyelocytes were increased to 28.5%, consistent with myelodysplastic syndrome progression to acute myeloid leukemia. The patient was treated with cyclophosphamide, vincristine, cytosine arabinoside and prednisone (COAP) combination therapy. Cytogenetic analysis with R-banding technique on unstimulated BM cells at admission revealed t(1;2) (q21;q37) chromosome translocation in 10 metaphases among 11 analyzed (90%) (Figure 1b) . Chromosomal translocation t(1;2) (q21;q37) was also confirmed by chromosomal painting (CP) using whole CP probes for chromosome 1 Letters to the Editor (digoxigenin-labeled, Oncor, Inc., Gaithersburg, MD, USA) and chromosome 2(biotin-labeled, Cambio, Cambridge, UK) ( Figure 1c) .
Chromosome translocation breakpoint on 1q21 was successfully narrowed into a region which was 15B16 kb upstream to the 5 0 end of the human Hornerin gene through combination of positional cloning strategy and fluorescence in situ hybridization (FISH) technique. Schema of genetic maps of 1q21 with STS markers as well as YAC, BAC/PAC and plasmid contigs localized around the breakpoint on chromosome 1q21 was shown in Figure 1a Human DNA insert from clone RP11-107M16 (NCBI accession number AL589986) is 151 kb containing three genes encoding 'fused gene'-type cornified envelope precursor proteins, trichohyalin, repetin and Hornerin, from centromere to telomere on the long arm of chromosome 1. The breakpoint on chromosome 1q21 was around Hornerin gene locus. In order to further characterize the breakpoint region on 1q21, we constructed a plasmid contig spanning the gap between BAC clones CIT-HSP-2301M16 and R-947A10 (Figure 1a 1 ). These plasmids contained human DNA fragments of 2B3 kb in average. DNAs from 2 or 3 plasmid clones were pooled together and labeled by nick-translation using Biotin-16-dUTP. FISH analysis was performed as above. Eventually, we identified that plasmid clones 903, 487 and 813, which formed one combination probe for FISH, covered the translocation breakpoint on 1q21. Figure 1g represented the split red signals of this combination probe. Human DNA inserts contained in these three plasmid clones were 5.4 kb in total, which indicated that the translocation breakpoint region was successfully narrowed into this 5.4 kb chromosome region on 1q21 by our FISH/ positional cloning procedure.
As we mentioned above, three 'fused gene'-type cornified envelope precursor protein coding genes with transcription direction from telomere to centromere are covered by RP11-107M16. In the case presented here with chromosome translocation t(1;2)(q21;q37), the breakpoint on 1q21 lays in a region 15B16 kb upstream to Hornerin gene (telomeric to Hornerin gene locus), where there was no disruption of the open reading frame (ORF) of Hornerin gene. However, reverse transcription-polymerase chain reaction (RT-PCR) revealed that the juxtaposition resulted in abnormal activation of Hornerin gene transcription in the patient's BM cells. As shown in Figure 2b , although there was no expression of Hornerin gene in non-patient BM samples, Hornerin gene transcript was detected in the BM sample from the present case with t(1;2)(q21;q37) by RT-nested PCR.
It was worth noting that in case #30, t(1;2)(q21;q37) was the only detectable cytogenetic abnormality and the vast majority of malignant cells from the patient's BM harbored this unique chromosome translocation. Thus, we speculated that the abnormal activation of Hornerin gene detected in the case presented here may play a crucial role in the development and/ or progression of MDS in this case. Human Hornerin, which has been just identified recently, is a member of the 'fused gene'-type cornified envelope precursor protein family (profilaggrin, trichohyalin, repetin and Hornerin). 3 Proteins in this family have EF-hand domains at the N-terminus followed by multiple tandem repeats. The EF-hand Ca 2 þ binding domain is highly homologic to that of S100 proteins, and these genes are thought to have evolved through fusion between genes of the S100 Ca 2 þ binding proteins and genes of cornified envelope precursor proteins.
Presently around 20 members of S100 Ca 2 þ binding proteins have been unveiled, many of which are encoded by genes located in a cluster on chromosome 1q21.
4 S100 proteins are characterized by common structural motifs including two EFhands that are separated by a hinge region and flanked by amino-and carboxyl-terminal domains. S100 proteins function as calcium sensor proteins, regulating the function of specific target proteins upon the activation by calcium binding to conservative EF-hand motifs. The carboxyl-terminal domain is variable among S100 proteins and is thought to give the specific biological activity of the individual proteins.
Several S100 proteins have been implicated in the progression of cancers in that they have altered levels of expression in cancer cells compared to normal cells in addition to involvement in the immune response, differentiation, cytoskeleton dynamics and enzyme activity. For example, S100B has been found to be overexpressed in melanoma, anaplastic astrocytoma and glioblastoma. [5] [6] [7] In the present study, the gene encoding Hornerin, a 'fused-gene'-type S100 protein, was abnormally activated in the AML case with t(1;2)(q21;q37) compared to non-patient BMs. Intriguingly, the expression of Hornerin gene was also detected in five among 90 analyzed BM specimens from patients suffering from a variety of malignant hematological diseases. Although cytogenetic analysis did not reveal any chromosome abnormality involving chromosome 1q21 in these five samples, some cryptal molecular mechanism might be able to trigger the upregulation of Hornerin gene expression in these samples. Whatever the underlying mechanisms are, the recurrent overexpression of Hornerin gene in BMs of leukemia patients may potentially contribute to its role in tumor development and/or progression.
Previous studies on 'fused gene'-type cornified envelope precursor proteins were focused on their physiological and pathological functions in keratinization. For instance, reduced amount of profilaggrin has been reported to be related to ichthyosis vulgaris. 8 We have reported here for the first time that the 'fused-gene'-type S100 proteins may also be involved in pathologies, in particular in neoplasia, of tissues other than epidermis. This can widen our knowledge of 'fused-gene'-type S100 proteins.
In this case, the translocation was comparable to those involving IgH in lymphoma in that chromosomal translocation results in the activation of oncogenes rather than the disruption of ORFs. Usually, chromosomal translocation causes the regulatory region of the oncogenes to be replaced by the regulatory region, including enhancer elements, of other genes. In order to unveil the genomic DNA sequence of the partner gene involved in t(1;2)(q21;q37) on chromosome 2q37, we tried Inverse PCR as described previously. However, due to the highly repetitive genomic sequence flanking the breakpoint on 1q21, we failed to design appropriate primers for successful inverse PCR. The possibility remains that a mysterious gene with active enhancer which was involved in t(1;2)(q21;q37) may be harbored on 2q37.
Interestingly, in present study, the expression of human Hornerin gene was also detected in normal skin (only by one round RT-PCR) and esophagus (nested RT-PCR) (Figure 2a) , which was similar to the expression profile of mouse Hornerin gene. 9 However, the present data seemed inconsistent with the human Hornerin gene expression profile reported in the original study of identification of human Hornerin gene. In that study, the authors demonstrated that human Hornerin gene was only expressed in vulva, in regenerating skin after wounding and in psoriatic skin, but was not detected in normal trunk skin and in most of other human tissues. 3 In terms of the different expressions of Hornerin in esophagus between present and previous studies, we believe that it was due to nested RT-PCR exploited by us, which is definitely more sensitive to detect lowexpressed transcript than regular RT-PCR. Meanwhile, the imparity of Hornerin gene expression in skin might result from the different origin of the skin samples employed in these two studies.
In summary, with the impressive progression of human genome project, a variety of genetic maps are completed gradually, which incredibly facilitates the physical chromosome mapping. In the present study, we successfully narrowed chromosome translocation breakpoint on 1q21 into a 5.4 kb region in a AML case with t(1;2)(q21;q37) by the FISH/positional cloning procedure on the patient's BM metaphases and identified the candidate gene involved. We reported here for the first time that inappropriate expression of 'fused gene'-type S100 protein, Hornerin, may play a role in the development of human malignant diseases. Further work will be required to clarify the functions of these 'fused-gene'-type S100 proteins under a variety of physiological and pathological conditions. . One micro liter of first-round PCR product at 1:100 dilution was used as template for the second-round PCR. (a) Hornerin transcript was detected in skin and esophagus but not in normal BM sample. In skin, the Hornerin transcript can be detected clearly by one-round PCR (224 bp PCR fragment). However, in esophagus, the transcript can only be detected by nested-PCR (115 bp PCR fragment). At 224 and 115 bp resulted in positive PCR products of Hornerin. (b) Hornerin transcript was detected in the BM sample from the patient (case #30). Skin sample was used as a positive control, while two nonpatient BM samples were used as negative control. PCR products were all confirmed by sequencing. RT-PCR of glyceraldehyde-3-phosphate dehydrogenase gene was used as internal control.
